The Current Ratio as of December 2025 (TTM) for Pharmala Biotech Holdings Inc. (MDMA.CN) is 2.10

According to Pharmala Biotech Holdings Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.10. This represents a change of 21.84% compared to the average of 1.72 of the last 4 quarters.

Pharmala Biotech Holdings Inc. (MDMA.CN) Historical Current Ratio (quarterly & annually)

How has MDMA.CN Current Ratio performed in the past?

The mean historical Current Ratio of Pharmala Biotech Holdings Inc. over the last ten years is 5.67. The current 2.10 Current Ratio has changed 3.60% with respect to the historical average. Over the past ten years (40 quarters), MDMA.CN's Current Ratio was at its highest in in the November 2021 quarter at 16.69. The Current Ratio was at its lowest in in the May 2021 quarter at 0.

Pharmala Biotech Holdings Inc. (MDMA.CN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Pharmala Biotech Holdings Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Pharmala Biotech Holdings Inc. (MDMA.CN) Average Current Ratio

How has MDMA.CN Current Ratio performed in the past?

The current Current Ratio of Pharmala Biotech Holdings Inc. (MDMA.CN) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Pharmala Biotech Holdings Inc. (MDMA.CN) Current Ratio vs. Peers

How is MDMA.CN’s Current Ratio compared to its peers?

Pharmala Biotech Holdings Inc.’s Current Ratio is greater than Marvel Biosciences Corp. (0.08), less than PharmaTher Holdings Ltd. (2.24), greater than BetterLife Pharma Inc. (0.04), less than Red Light Holland Corp. (5.59), greater than Medicure Inc. (1.48), greater than Hemostemix Inc. (1.54), greater than Comprehensive Healthcare Systems, Inc. (0.06), less than Glow Lifetech Corp. (2.16), greater than Britannia Life Sciences Inc. (1.00), greater than PreveCeutical Medical Inc. (0.04),

Build a custom stock screener for Pharmala Biotech Holdings Inc. (MDMA.CN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharmala Biotech Holdings Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pharmala Biotech Holdings Inc. (MDMA.CN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pharmala Biotech Holdings Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.